申请人:Onconova Therapeutics, Inc.
公开号:EP2769719A1
公开(公告)日:2014-08-27
Solution and suspension formulations are provided for administration prior to or after exposure to ionizing radiation for reducing toxic effects of the radiation in a subject which comprises an effective amount of at least one radioprotective α, β unsaturated aryl sulfone wherein the composition has a pH within the range of about 8 to about 9.
本发明提供了溶液和悬浮液制剂,用于在电离辐射照射前或照射后给药,以减少辐射对受试者的毒性影响,该制剂包含有效量的至少一种辐射保护性 α、β 不饱和芳基砜,其中组合物的 pH 值在约 8 到约 9 的范围内。